25,076 Shares in Amrize Ltd $AMRZ Purchased by Knights of Columbus Asset Advisors LLC

Knights of Columbus Asset Advisors LLC bought a new stake in Amrize Ltd (NYSE:AMRZFree Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 25,076 shares of the company’s stock, valued at approximately $1,217,000.

Several other hedge funds also recently modified their holdings of the company. Global Retirement Partners LLC purchased a new stake in shares of Amrize during the third quarter worth about $48,000. BNP Paribas Financial Markets acquired a new stake in Amrize during the second quarter worth approximately $59,000. Groupe la Francaise purchased a new stake in Amrize in the 2nd quarter worth approximately $60,000. Allianz SE acquired a new position in Amrize in the 2nd quarter valued at $80,000. Finally, Osaic Holdings Inc. acquired a new position in Amrize in the 2nd quarter valued at $90,000.

Insider Buying and Selling

In other Amrize news, Director Nicholas C. Gangestad acquired 2,000 shares of the firm’s stock in a transaction on Wednesday, November 19th. The stock was bought at an average cost of $47.34 per share, for a total transaction of $94,680.00. Following the completion of the purchase, the director directly owned 4,958 shares in the company, valued at $234,711.72. This represents a 67.61% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Jaime Hill bought 4,000 shares of the business’s stock in a transaction dated Tuesday, November 4th. The stock was acquired at an average cost of $50.69 per share, for a total transaction of $202,760.00. Following the purchase, the insider owned 18,101 shares in the company, valued at approximately $917,539.69. This trade represents a 28.37% increase in their position. The SEC filing for this purchase provides additional information.

Amrize Price Performance

NYSE AMRZ opened at $52.64 on Friday. The company has a quick ratio of 0.97, a current ratio of 1.45 and a debt-to-equity ratio of 0.38. Amrize Ltd has a 1-year low of $44.12 and a 1-year high of $58.11. The firm has a market cap of $29.11 billion and a price-to-earnings ratio of 28.61. The company has a 50-day moving average price of $54.24.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on AMRZ. Royal Bank Of Canada downgraded Amrize from an “outperform” rating to a “sector perform” rating and lifted their price objective for the company from $56.00 to $60.00 in a research report on Monday, December 8th. Stephens started coverage on Amrize in a research report on Friday, November 14th. They set an “overweight” rating and a $60.00 target price on the stock. Oddo Bhf initiated coverage on Amrize in a report on Monday, November 3rd. They issued a “neutral” rating for the company. Wells Fargo & Company upped their price objective on shares of Amrize from $58.00 to $59.00 and gave the company an “overweight” rating in a research note on Thursday. Finally, UBS Group raised their target price on shares of Amrize from $53.00 to $57.00 and gave the stock a “neutral” rating in a research report on Thursday, January 8th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat, Amrize has a consensus rating of “Moderate Buy” and an average target price of $60.75.

Check Out Our Latest Research Report on AMRZ

Amrize Profile

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

See Also

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZFree Report).

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.